2024 年度新增对外担保额度预计的核查意见 中信证券股份有限公司 关于上海合晶硅材料股份有限公司 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为上海 合晶硅材料股份有限公司（以下简称"上海合晶"、"公司"）首次公开发行股 票并在科创板上市的保荐机构。根据《证券发行上市保荐业务管理办法》《上海 证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指 引第 1 号——规范运作》等有关规定，对上海合晶 2024 年度新增对外担保额度 预计的事项进行了核查。具体如下： 一、担保情况概述 1、担保基本情况 上海合晶为满足全资子公司郑州合晶硅材料有限公司（以下简称"郑州合晶"） 业务发展资金需要，保证公司业务顺利开展，结合郑州合晶未来发展计划，2024 年度拟在郑州合晶申请贷款业务需要时为其提供对外担保，担保总额不超过人民 币 150,000 万元。实际贷款及担保发生时，担保金额、担保期限、担保费率等内 容，由上海合晶及郑州合晶与贷款银行等金融机构在以上额度内共同协商确定， 相关担保事项以正式签署的担保文件为准。 公司董事会授权公司董事长及其授权人士根据公司实际经营情况的需要，在 担保额 ...

证券代码：688584 证券简称：上海合晶 公告编号：2024-015 上海合晶硅材料股份有限公司 关于确认2023年度日常关联交易 及2024年度日常关联交易预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1、董事会审议情况和关联董事回避情况 公司于2024年4月25日召开第二届董事会第十二次会议，以5票同意、0票反对、 0票弃权的表决结果通过了《关于确认2023年度日常关联交易及2024年度日常关联 交易预计的议案》。董事会上，关联董事刘苏生、焦平海、邰中和及毛瑞源对该议 案回避表决，其余非关联董事对该议案一致同意。 2、独立董事专门会议的审查意见 公司于2024年4月25日召开第二届董事会第一次独立董事专门会议，审议通过 了上述议案，并形成以下意见：公司2023年已发生的日常关联交易事项公平、合理， 不存在损害公司和其他非关联方股东利益的情形。公司2024年度预计发生的日常关 联交易事项为公司开展正常经营管理所需，公司自身业务与关联方的业务存在一定 1 的关联性，也存在交易的必要性，关联交 ...

证券代码：688584 证券简称：上海合晶 公告编号：2024-017 上海合晶硅材料股份有限公司 关于使用募集资金置换预先投入募投项目及已支付 发行费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海合晶硅材料股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日召开 了第二届董事会第十二次会议及第二届监事会第十二次会议，审议通过了《关于使 用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的议案》，同意公 司使用募集资金人民币 15,618.78 万元置换预先投入募投项目的自筹资金、使用募 集资金人民币24,325,568.88元（不含税）置换已支付发行费用的自筹资金。前述事 项符合募集资金到账后 6 个月内进行置换的规定。公司监事会发表了明确同意的意 见，保荐机构中信证券股份有限公司（以下简称"保荐机构"）对本事项出具了明 确的核查意见。现将具体情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会（以下简称"中国证监会"）出具《关于同意 上海合晶硅材料股份有限公司首 ...

（一）个人工作履历、专业背景以及兼职情况 徐征先生，1959 年出生，博士研究生学历，中国国籍，无境外永久居留权。 徐征先生 1983 年至 1987 年任中国科学院长春光学精密器械与物理研究所助工； 1987 年至 1996 年任天津理工大学工程师；1996 年至今，任北京交通大学教授。 2020 年 8 月至今，任公司独立董事。 （二）独立性说明 上海合晶 688584 上海合晶硅材料股份有限公司 2023年度独立董事述职报告（徐征） 作为上海合晶硅材料股份有限公司（以下简称"公司"）的独立董事，2023年 度我严格按照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司独立董事管理办法》《上 海证券交易所科创板股票上市规则》等法律法规及《上海合晶硅材料股份有限公司 章程》（以下简称"《公司章程》"）、《上海合晶硅材料股份有限公司独立董事工 作制度》（以下简称"《独立董事工作制度》"）的有关规定，诚实、勤勉、独立地 履行独立董事职责，积极出席相关会议，认真审议董事会各项议案，对公司重大事 项发表了独立、客观、公正的独立意见，切实维护公司和全体 ...

证券代码：688584 证券简称：上海合晶 公告编号：2024-019 为满足全资子公司郑州合晶业务发展资金需要，保证公司业务顺利开展，结 合郑州合晶未来发展计划，2024 年度公司拟在郑州合晶申请贷款业务需要时为其 提供担保，担保总额不超过人民币 150,000 万元，实际贷款及担保发生时，担保金 额、担保期限、担保费率等内容，由公司及郑州合晶与贷款银行等金融机构在以上 额度内共同协商确定，相关担保事项以正式签署的担保文件为准。担保项下之银行 授信之用途及涉及项目，应符合公司经批准的经营计划，并根据《公司章程》的规 定，履行并获得相应批准。 1 上海合晶硅材料股份有限公司 关于2024年度新增对外担保额度预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 上海合晶硅材料股份有限公司（以下简称"公司"）此次对外担保额度预 计事项的被担保方为全资子公司郑州合晶硅材料有限公司（以下简称"郑州合 晶"）。 2024 年度，公司拟新增对外担保额度预计不超过人民币 150,000 万元。截 至 2023 年 ...

上海合晶 688584 上海合晶硅材料股份有限公司 2023年度独立董事述职报告（邓泗堂） 作为上海合晶硅材料股份有限公司（以下简称"公司"）的独立董事，2023年 度我严格按照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司独立董事管理办法》《上 海证券交易所科创板股票上市规则》等法律法规及《上海合晶硅材料股份有限公司 章程》（以下简称"《公司章程》"）、《上海合晶硅材料股份有限公司独立董事工 作制度》（以下简称"《独立董事工作制度》"）的有关规定，诚实、勤勉、独立地 履行独立董事职责，积极出席相关会议，认真审议董事会各项议案，对公司重大事 项发表了独立、客观、公正的独立意见，切实维护公司和全体股东的合法权益，促 进公司规范运作，充分发挥了独立董事的独立作用。现将2023年度公司独立董事的 述职情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 邓泗堂先生，1956年出生，硕士研究生学历，中国台湾籍，具有中国大陆及 中国台湾注册会计师资格，证券分析师。邓泗堂先生1980年至1981年任张清煌会计 师事务所查账员 ...

中信证券股份有限公司关于 上海合晶硅材料股份有限公司使用募集资金向全资子公司 增资以实施募投项目的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为上海 合晶硅材料股份有限公司（以下简称"公司"、"上海合晶"或"发行人"）首次 公开发行股票并在科创板上市的保荐机构。根据《证券发行上市保荐业务管理办 法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自 律监管指引第 1 号——规范运作》及《上市公司监管指引第 2 号——上市公司募 集资金管理和使用的监管要求》等有关规定，对公司使用募集资金向全资子公司 增资以实施募投项目的事项进行了核查，核查情况如下： 一、 募集资金基本情况 经中国证券监督管理委员会出具《关于同意上海合晶硅材料股份有限公司首 次公开发行股票注册的批复》（证监许可[2023]2253 号）核准，公司首次向社会 公开发行人民币普通股 66,206,036 股，每股发行价格为 22.66 元，募集资金总额 为 150,022.88 万元，扣除新股发行费用（不含增值税）后，募集资金净额为 139,017.50 万元。前述募集资金已经全部到位，并经立信会计师事务 ...

上海合晶硅材料股份有限公司 募集资金置换专项鉴证报告 [司工 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mot.gov.cn）"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mot.gov.cn）"进行查 ： 关于上海合晶硅材料股份有限公司 以募集资金置换预先投入募投项目 及已支付发行费用的自筹资金的专项鉴证报告 信会师报字[2024]第 ZA11168 号 上海合晶硅材料股份有限公司全体股东: 我们接受委托,对后附的上海合晶硅材料股份有限公司(以下 简称"贵公司"或"公司")管理层编制的截至 2024年 4 月 9 日《上海 合晶硅材料股份有限公司关于公司以募集资金置换预先投入募投项 目及已支付发行费用的自筹资金的专项说明》进行专项鉴证。 一、管理层的责任 按照《上市公司监管指引第 2 号-- 上市公司募集资金管理和使 用的监管要求(2022年修订)》及《上海证券交易所科创板上市公司 自律监管指引第 1 号-规范运作(2023年 12 月修订 》等相关文件 的规定,编制《上海合晶硅材料股份有限公司关于公司以募集资金置 换预先投入 ...

Financial Performance - The company's operating revenue for 2023 was CNY 134,817.37 million, a decrease of 13.38% compared to CNY 155,641.36 million in 2022[23]. - The net profit attributable to shareholders for 2023 was CNY 24,686.10 million, down 32.35% from CNY 36,488.92 million in 2022[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 21,322.79 million, a decrease of 40.23% compared to CNY 35,673.62 million in 2022[23]. - The net cash flow from operating activities for 2023 was CNY 57,836.63 million, down 23.46% from CNY 75,560.19 million in 2022[23]. - The company's total assets at the end of 2023 were CNY 367,344.18 million, a decrease of 2.10% from CNY 375,206.05 million at the end of 2022[23]. - The net assets attributable to shareholders increased by 7.99% to CNY 278,881.78 million at the end of 2023, compared to CNY 258,250.75 million at the end of 2022[23]. - The basic earnings per share for 2023 were CNY 0.41, down 32.79% from CNY 0.61 in 2022[24]. - The company's revenue for the reporting period was 1,348.17 million yuan, representing a year-on-year decrease of 13.38% due to weak demand in the communications and office sectors[76]. Dividend and Shareholder Information - The proposed cash dividend for 2023 is 3 CNY per 10 shares, totaling approximately 198.62 million CNY, which represents 80.46% of the net profit attributable to shareholders of the parent company[6]. - The company plans to hold a shareholders' meeting to approve the profit distribution proposal[6]. - The total number of employees in the parent company and major subsidiaries is 1,000, with 703 in production, 20 in sales, 140 in technology, 29 in finance, and 108 in administration[147]. - The company has established a training plan to develop a skilled workforce, focusing on technical and managerial talent through various training programs[149]. Risks and Challenges - The company has not reported any significant risks that could materially affect its operations during the reporting period[4]. - The company has outlined potential risks related to forward-looking statements in its report[7]. - The company faced risks related to international trade disputes, which could impact its operations and partnerships[82]. - The company is at risk of losing tax incentives related to high-tech enterprise status if relevant policies change or if it fails to maintain its qualifications[76]. - The company is experiencing pressure on gross margins due to cyclical downturns in the communications and office markets, leading to increased production costs[74]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 8.65% in 2023, up from 8.06% in 2022[24]. - The company invested 116.64 million yuan in 35 R&D projects during the reporting period, with 11 projects reaching mass production stage[35]. - The company applied for 81 patents during the reporting period, including 24 invention patents and 57 utility model patents[35]. - The company is focusing on developing high-performance products for CMOS image sensors (CIS), targeting features such as high signal-to-noise ratio and low power consumption[48]. - The company is committed to continuous R&D investment to maintain its competitive edge in semiconductor technology and production capabilities[51]. Market and Industry Outlook - The global semiconductor industry sales in 2023 were reported at 520.1 billion USD, a decline of 9.4% year-on-year, reflecting ongoing adjustments in the market[32]. - The long-term outlook for the semiconductor industry remains positive, driven by advancements in AI and new energy technologies, which are expected to boost market demand for power devices[33]. - The company is positioned to benefit from the domestic substitution trend in the semiconductor industry, as reliance on imports remains high[43]. - The company anticipates a recovery in demand as the macroeconomic environment improves, projecting long-term growth in the semiconductor industry[77]. Corporate Governance - The company has received a standard unqualified audit opinion from its accounting firm, indicating the financial statements are accurate and complete[5]. - The company has established a comprehensive internal control and governance mechanism to mitigate financial and non-financial risks[36]. - The company has not reported any instances where more than half of the board members could not ensure the authenticity and completeness of the annual report[9]. - The company maintains a governance structure that complies with relevant laws and regulations, ensuring effective operation and protection of shareholder rights[120]. Environmental and Social Responsibility - The company invested approximately 24.55 million yuan in environmental protection during the reporting period[168]. - The company has implemented carbon reduction measures that resulted in a reduction of 4,200 tons of CO2 equivalent emissions[175]. - The company has a dedicated environmental safety management department and follows international standards such as ISO45001 and ISO14001[174]. - The company donated a total of 80,000 yuan to charity in 2023, including 40,000 yuan to the Shanghai Charity Foundation[179]. Strategic Initiatives - The company plans to continue focusing on market expansion and new product development to enhance future growth prospects[1]. - The company is focusing on a strategy of "strengthening 8-inch and expanding 12-inch" wafer production to navigate the current market challenges[33]. - The company aims to enhance its technical capabilities in the 12-inch semiconductor silicon epitaxy field through investment projects, addressing the low market share of domestic silicon wafer companies[113]. - The company plans to increase its annual production capacity of 8-inch equivalent epitaxial wafers to approximately 3.7 million pieces by the end of 2023[115].

Financial Performance - The company's operating revenue for Q1 2024 was CNY 249.07 million, a decrease of 28.00% compared to the same period last year[4]. - The net profit attributable to shareholders was CNY 18.27 million, down 69.22% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 15.50 million, a decline of 72.16% compared to the previous year[4]. - The basic earnings per share were CNY 0.03, a decrease of 72.41% compared to the same period last year[4]. - Total operating revenue for Q1 2024 was ¥249,074,351.22, a decrease of 28.1% compared to ¥345,935,973.20 in Q1 2023[18]. - Net profit for Q1 2024 was ¥18,266,763.15, a decline of 69.2% from ¥59,345,537.87 in Q1 2023[19]. - Basic and diluted earnings per share for Q1 2024 were both ¥0.03, compared to ¥0.10 in Q1 2023[20]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY 53.01 million, representing a decrease of 55.80% year-on-year[4]. - The company’s cash flow from operating activities showed a significant decline, reflecting challenges in revenue generation[22]. - The net cash flow from operating activities for Q1 2024 was $53,011,239.87, a decrease from $119,936,160.74 in the previous period[23]. - The cash inflow from operating activities was $250,133,169.03, down from $417,633,863.95 in the previous period[23]. - The cash balance at the end of the period was $1,683,050,900.45, an increase from $451,507,483.54 at the end of the previous period[24]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,965.90 million, an increase of 35.18% from the end of the previous year[5]. - The total current assets as of March 31, 2024, amounted to ¥2,324,451,123.22, a significant increase from ¥1,009,142,340.47 as of December 31, 2023, indicating a growth of approximately 130%[12]. - The total assets of the company as of March 31, 2024, were ¥4,965,902,608.01, compared to ¥3,673,441,770.36 at the end of 2023, representing an increase of approximately 35.2%[13]. - Total liabilities as of Q1 2024 were ¥762,157,980.86, down 13.8% from ¥884,623,931.48 in Q1 2023[15]. - The company reported a decrease in short-term borrowings to ¥40,589,864.58 from ¥120,229,023.46, a reduction of about 66.2%[13]. Research and Development - Research and development expenses totaled CNY 23.58 million, accounting for 9.47% of operating revenue, an increase of 0.8 percentage points[5]. - Research and development expenses for Q1 2024 were ¥23,582,848.80, a decrease of 21.5% from ¥29,993,812.58 in Q1 2023[18]. Shareholder Equity - Shareholders' equity attributable to the parent company was CNY 4,203.74 million, up 50.74% year-on-year[5]. - Total equity attributable to shareholders was ¥4,203,744,627.15 in Q1 2024, an increase of 50.9% from ¥2,788,817,838.88 in Q1 2023[15]. Non-Recurring Gains - The company reported non-recurring gains of CNY 276.53 million after tax, primarily from government subsidies[6]. Other Observations - The company has not reported any significant changes in the shareholder structure or any new strategies during the quarter[11]. - There were no new product launches or technological advancements mentioned in the earnings call[11]. - The company did not provide specific guidance for future performance or market expansion plans in the current report[11].